HEPATOLOGY

Scope & Guideline

Championing excellence in liver research since 1981.

Introduction

Explore the comprehensive scope of HEPATOLOGY through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore HEPATOLOGY in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0270-9139
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1981 to 2024
AbbreviationHEPATOLOGY / Hepatology
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal 'Hepatology' focuses on advancing the understanding, prevention, diagnosis, and treatment of liver diseases through rigorous research and clinical studies. Its scope encompasses a broad range of topics related to hepatology, including but not limited to viral hepatitis, liver cancer, fatty liver disease, and liver transplantation. The journal aims to disseminate high-quality research findings that can influence clinical practice and improve patient outcomes.
  1. Viral Hepatitis Research:
    This area includes studies on the epidemiology, pathogenesis, and treatment of hepatitis viruses (A, B, C, D, and E), focusing on novel antiviral therapies and their clinical implications.
  2. Liver Cancer and Oncology:
    Research on hepatocellular carcinoma (HCC) and cholangiocarcinoma, including mechanisms of tumorigenesis, therapeutic strategies, and outcomes of various treatment modalities.
  3. Liver Disease Mechanisms:
    Investigations into the cellular and molecular mechanisms underlying liver diseases such as non-alcoholic fatty liver disease (NAFLD), alcohol-related liver disease, and autoimmune liver conditions.
  4. Transplantation and Regenerative Medicine:
    Studies focused on liver transplantation, including donor selection, post-transplant outcomes, and the role of stem cells and organoids in liver regeneration.
  5. Clinical Guidelines and Practice:
    The journal publishes consensus guidelines and practice recommendations to improve the management of liver diseases, emphasizing evidence-based approaches.
  6. Innovative Diagnostic Techniques:
    Research utilizing advanced diagnostic modalities such as imaging techniques, serum biomarkers, and non-invasive fibrosis assessment methods for better disease characterization.
  7. Public Health and Epidemiology:
    Articles addressing the epidemiological aspects of liver diseases, including the impact of lifestyle factors, health disparities, and public health initiatives for prevention and management.
Recent publications in 'Hepatology' indicate several trending and emerging themes that reflect the evolving landscape of liver disease research. These themes highlight innovative approaches, novel therapeutic strategies, and a comprehensive understanding of liver disease mechanisms.
  1. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD):
    Research on MAFLD is gaining momentum, emphasizing the need for updated diagnostic criteria and treatment strategies that address the metabolic aspects of liver disease.
  2. Artificial Intelligence in Hepatology:
    The integration of AI and machine learning techniques for diagnosing liver diseases, predicting outcomes, and personalizing treatment regimens is becoming increasingly prominent.
  3. Personalized Medicine Approaches:
    Emerging studies focusing on tailoring therapies based on individual patient characteristics, genetic profiles, and specific disease phenotypes are trending.
  4. Non-Invasive Diagnostic Modalities:
    There is a marked increase in research on non-invasive techniques for diagnosing liver conditions, including transient elastography, MRI-based assessments, and blood-based biomarkers.
  5. Gut-Liver Axis Research:
    The exploration of the gut microbiome's role in liver disease pathogenesis and treatment responses is an emerging area of interest, linking gastrointestinal health to liver outcomes.
  6. Longitudinal Studies and Real-World Evidence:
    There is a growing trend towards longitudinal studies that provide real-world evidence on the effectiveness of therapies and the natural history of liver diseases.
  7. Public Health Interventions:
    Research focusing on the impact of public health policies and community-based interventions for liver disease prevention and management is gaining traction.

Declining or Waning

While 'Hepatology' has consistently covered various aspects of liver diseases, certain research areas appear to be declining in prominence based on recent publications. This may reflect shifting priorities within the field, advancements in understanding, or the saturation of existing knowledge in those areas.
  1. Traditional Liver Biopsy Techniques:
    There has been a noticeable decline in studies focused on traditional liver biopsy methods as non-invasive techniques for assessing liver fibrosis gain popularity and acceptance.
  2. Alcohol-Induced Liver Disease:
    Although still an important topic, research specifically focused on classic alcohol-induced liver disease may be waning as attention shifts towards broader metabolic dysfunction-associated liver diseases (MASH) and their multifactorial causes.
  3. Basic Science Studies:
    The journal has seen fewer purely basic science studies as there is a growing emphasis on translational research that can directly impact clinical practice and patient care.
  4. Viral Hepatitis Monotherapy Studies:
    Research focusing solely on monotherapy for hepatitis treatments is declining in favor of combination therapies that target multiple pathways and improve treatment efficacy.
  5. Outdated Diagnostic Biomarkers:
    Research on older biomarkers for liver disease diagnosis is decreasing as newer, more effective biomarkers are developed and validated.

Similar Journals

JOURNAL OF HEPATOLOGY

Charting New Territories in Liver Health Science
Publisher: ELSEVIERISSN: 0168-8278Frequency: 12 issues/year

JOURNAL OF HEPATOLOGY, published by Elsevier, stands as a preeminent source in the field of Hepatology, with its impact underscored by a remarkable 2023 Category Quartile of Q1 and a Scopus rank of 3rd out of 82 journals, placing it in the 96th percentile for the discipline. Since its inception in 1985, this journal has been a vital conduit for the dissemination of pioneering research, clinical studies, and reviews related to liver diseases and their impact on global health. Although it currently does not offer open access options, the journal is committed to providing top-tier content to its readership—researchers, medical professionals, and students—in order to advance knowledge and foster innovation in hepatology. With a broad and inclusive scope, it aims to cover significant breakthroughs, therapeutic advancements, and epidemiological studies, continually pushing the boundaries of understanding in liver health. The journal is based in Amsterdam, Netherlands, and remains an essential resource for those dedicated to the progression of hepatologic science.

Journal of Clinical and Experimental Hepatology

Transforming insights into impactful liver care.
Publisher: ELSEVIER - DIVISION REED ELSEVIER INDIA PVT LTDISSN: 0973-6883Frequency: 4 issues/year

The Journal of Clinical and Experimental Hepatology, published by Elsevier - Division Reed Elsevier India Pvt Ltd, is a premier platform dedicated to advancing the field of hepatology. With an ISSN of 0973-6883 and an E-ISSN of 2213-3453, this journal has gained recognition for its impactful contributions to both clinical practice and scientific research in the domain of liver health. Ranking in the Q2 quartile for Hepatology in 2023 and positioned at 33rd out of 82 in Scopus’s Hepatology category, it reflects a robust impact factor and a commitment to publishing high-quality, peer-reviewed articles. Researchers, clinicians, and students can engage with a wealth of open-access content covering the latest advancements, challenges, and insights in hepatology, as the journal aims to disseminate knowledge from 2011 through 2025. Join the community of experts as we explore critical developments in the understanding and treatment of liver diseases.

JGH Open

Unlocking Insights in Gastrointestinal Health
Publisher: WILEYISSN: 2397-9070Frequency: 1 issue/year

JGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.

Canadian Liver Journal

Exploring New Frontiers in Liver Disease Management.
Publisher: UNIV TORONTO PRESS INCISSN: Frequency: 4 issues/year

Canadian Liver Journal, published by University of Toronto Press Inc., offers a dedicated platform for the dissemination of cutting-edge research in the field of Hepatology. With an E-ISSN of 2561-4444, this journal plays a pivotal role in advancing knowledge related to liver diseases and therapies, currently ranked in the 3rd quartile (Q3) for the 2023 category in Hepatology—a reflection of its growing influence in the biomedical research community. The journal, which has been in circulation since 2018 and sets its sights on contributing valuable insights until 2024, aims to engage researchers, clinicians, and students alike by providing a rigorous peer-reviewed environment for sharing findings, case studies, and reviews pertinent to liver health. Through its commitment to excellence and scholarly impact, the Canadian Liver Journal serves as an essential resource for those dedicated to combating liver diseases and enhancing patient care.

Clinics in Liver Disease

Fostering knowledge and innovation in liver disease research.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 1089-3261Frequency: 4 issues/year

Clinics in Liver Disease is an esteemed peer-reviewed journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of hepatology. Established in 1997 and covering a broad range of topics within liver disease research, this journal serves as a vital resource for researchers, clinicians, and students engaged in the study of liver health and diseases. With a commendable impact factor placing it within the Q2 category in Hepatology and ranking #32 out of 82 in the Scopus classifications, it consistently disseminates high-quality research and clinical insights. The journal’s commitment to promoting understanding and management of liver diseases is reflected in its rigorous editorial standards and comprehensive review processes. Although not an open-access publication, Clinics in Liver Disease offers subscription options that ensure accessibility to up-to-date research and reviews critical for both academic and clinical success.

Hepatology Forum

Empowering knowledge exchange for liver disease advancements.
Publisher: KARE PUBLISSN: 1307-5888Frequency: 4 issues/year

Hepatology Forum is an esteemed journal dedicated to disseminating cutting-edge research and insights in the fields of gastroenterology and hepatology. Published by KARE PUBL in Turkey, this journal serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to advance their knowledge and practices related to liver diseases and gastrointestinal disorders. With an ISSN of 1307-5888 and an E-ISSN of 2757-7392, it features peer-reviewed articles that encompass a wide range of topics from basic research to clinical applications. Although categorized in the Q3 quartile for both gastroenterology and hepatology in 2023, Hepatology Forum continues to show significant potential for growth and impact, as evidenced by its Scopus rankings. Through its commitment to open scientific exchange, the journal not only facilitates the sharing of innovative methodologies and findings but also fosters networking among professionals in the field. As it converges through the years from 2020 to 2024, Hepatology Forum remains an important resource for the advancement of liver health and diseases, appealing to both established experts and emerging scholars alike.

BMJ Open Gastroenterology

Advancing Gastroenterology Through Open Access Research
Publisher: BMJ PUBLISHING GROUPISSN: 2054-4774Frequency: 1 issue/year

BMJ Open Gastroenterology is a premier open access journal published by the esteemed BMJ Publishing Group, focusing on the dynamic and evolving field of gastroenterology. Established in 2014, the journal has rapidly ascended in stature, reflected in its impressive 2023 Q1 ranking in gastroenterology and its position within the top 25% of journals in the category according to Scopus. With a mission to disseminate high-quality, peer-reviewed research with global significance, the journal provides a vital platform for researchers, professionals, and students alike to share their findings and advancements in gastrointestinal medicine. Operating from its headquarters in London, England, the journal's open access format ensures wide visibility and accessibility of cutting-edge research, making it an invaluable resource for those dedicated to improving patient care and driving innovation in gastroenterological sciences. By engaging with this journal, contributors and readers can stay at the forefront of critical developments in the field, fostering a collaborative environment for knowledge exchange.

Hepatology International

Innovating hepatology for a healthier tomorrow.
Publisher: SPRINGERISSN: 1936-0533Frequency: 4 issues/year

Hepatology International is a premier academic journal dedicated to advancing the field of liver research and hepatology. Published by SPRINGER, this journal boasts a prestigious Q1 ranking in Hepatology as of 2023, underscoring its commitment to high-quality research dissemination. The journal’s scope encompasses a wide range of topics related to liver disease, including clinical, translational, and basic science studies. With its impact factor reflecting its relevance and influence in the field, Hepatology International serves as an essential resource for researchers, clinicians, and students aiming to keep abreast of the latest developments and breakthroughs. Though traditionally a subscription-based journal, it offers a vast array of insightful articles that contribute significantly to our understanding of hepatological conditions. The journal continues its trajectory of growth since its inception in 2008, anticipating a convergence of knowledge and innovation through to 2024. Located in the heart of New York City, this journal not only represents a crucial platform for global hepatology research but also fosters a collaborative community of experts dedicated to improving liver health worldwide.

World Journal of Hepatology

Pioneering insights into hepatology for a healthier world.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1948-5182Frequency: 12 issues/year

World Journal of Hepatology is a premier academic journal dedicated to advancing the field of hepatology. Published by BAISHIDENG PUBLISHING GROUP INC, this journal serves as a crucial platform for disseminating innovative research findings and critical reviews from around the globe. With its ISSN 1948-5182 and E-ISSN 1948-5182, the journal has established a notable presence since its inception in 2009, covering a wide range of topics relevant to liver diseases, including but not limited to hepatitis, liver cancer, and metabolic liver disorders. Currently ranked 41/82 in the field of hepatology by Scopus, representing the 50th percentile, it has achieved a Q3 quartile ranking in the 2023 category, underscoring its growing influence in the medical community. With a commitment to open access for its readership, the World Journal of Hepatology enriches the global discourse on liver health and disease management, making it an essential resource for researchers, clinicians, and students alike.

Gastroenterologia y Hepatologia

Fostering innovation in the diagnosis and treatment of liver diseases.
Publisher: ELSEVIER ESPANA SLUISSN: 0210-5705Frequency: 10 issues/year

Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.